Millennium Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-143,459
Closed -$1.15M – 7844
2021
Q4
$1.15M Buy
+143,459
New +$1.68M ﹤0.01% 4277
2021
Q3
– Sell
-33,956
Closed -$469K – 7445
2021
Q2
$469K Buy
33,956
+15,574
+85% +$184K ﹤0.01% 5366
2021
Q1
$166K Buy
18,382
+3,056
+20% +$22.3K ﹤0.01% 5555
2020
Q4
$85K Sell
15,326
-24,224
-61% -$107K ﹤0.01% 5043
2020
Q3
$128K Sell
39,550
-1,157
-3% -$3.87K ﹤0.01% 4182
2020
Q2
$129K Sell
40,707
-911
-2% -$2.75K ﹤0.01% 3941
2020
Q1
$94K Buy
41,618
+670
+2% +$3.07K ﹤0.01% 3559
2019
Q4
$179K Sell
40,948
-11,015
-21% -$51.8K ﹤0.01% 3906
2019
Q3
$265K Buy
51,963
+2,050
+4% +$11.9K ﹤0.01% 3627
2019
Q2
$359K Sell
49,913
-2,362
-5% -$12.8K ﹤0.01% 3443
2019
Q1
$274K Sell
52,275
-4,938
-9% -$24.1K ﹤0.01% 3592
2018
Q4
$88K Sell
57,213
-28,996
-34% -$103K ﹤0.01% 3553
2018
Q3
$349K Buy
+86,209
New +$324K ﹤0.01% 3408
2015
Q3
– Sell
-4,023
Closed -$409K – 3826
2015
Q2
$409K Buy
+4,023
New +$416K ﹤0.01% 2737
2014
Q2
– Sell
-3,125
Closed -$252K – 4009
2014
Q1
$252K Buy
+3,125
New +$286K ﹤0.01% 3052

Other funds holding PLXP

Millennium Management's PLXP Position: Q1 2022 in Review

Millennium Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2022, closing a stake of 143,459 shares — an estimated $1.15M sold.

Millennium Management first reported a position in PLXP in Q1 2014 and held it in 15 quarters. The position peaked at $1.15M in Q4 2021. 50 funds tracked by Wall St. Rank hold PLXP as of Q1 2022.

  • Millennium Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Millennium Management sold 143,459 PLx Pharma Inc. Common Stock shares in Q1 2022, an estimated $1.15M.
  • Millennium Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2014 and held it in 15 quarters.
  • Millennium Management's PLx Pharma Inc. Common Stock position peaked at $1.15M in Q4 2021.
  • 50 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.